A study to assess the effect of verinurad on the electric activity of the heart

Trial Identifier: D5495C00012
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT04256629
Start Date: March 2020
Primary Completion Date: August 2020
Study Completion Date: August 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050